You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Selegiline - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for selegiline and what is the scope of patent protection?

Selegiline is the generic ingredient in four branded drugs marketed by Somerset, Norvium Bioscience, Apotex, Lannett Co Inc, Novitium Pharma, Rising, Bausch, Apotex Inc, Chartwell Molecules, Cosette, Dash Pharms Natco, G And W Labs Inc, Kenton, and MLV, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for selegiline. One supplier is listed for this compound.

Summary for selegiline
Drug Prices for selegiline

See drug prices for selegiline

Recent Clinical Trials for selegiline

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of IbadanPhase 1/Phase 2
E-Group ICT Software Informatikai Zrt.Phase 2
László MangelPhase 2

See all selegiline clinical trials

Medical Subject Heading (MeSH) Categories for selegiline
Anatomical Therapeutic Chemical (ATC) Classes for selegiline

US Patents and Regulatory Information for selegiline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Molecules SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074565-001 Aug 2, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Kenton SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074912-001 Apr 30, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mlv SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074672-001 Apr 1, 1997 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience ELDEPRYL selegiline hydrochloride CAPSULE;ORAL 020647-001 May 15, 1996 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for selegiline

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 ⤷  Sign Up ⤷  Sign Up
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006 ⤷  Sign Up ⤷  Sign Up
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006 ⤷  Sign Up ⤷  Sign Up
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.